HBK Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30,000
Closed -$4.65M 436
2023
Q1
$4.65M Buy
+30,000
New +$4.84M 0.03% 102
2022
Q4
Sell
-530,900
Closed -$86.7M 121
2022
Q3
$86.7M Buy
530,900
+198,400
+60% +$33.6M 0.61% 16
2022
Q2
$59M Buy
+332,500
New +$59.2M 0.33% 23
2022
Q1
Sell
-6,100
Closed -$1.04M 764
2021
Q4
$1.04M Sell
6,100
-40,300
-87% -$6.6M ﹤0.01% 470
2021
Q3
$7.49M Sell
46,400
-1,700
-4% -$290K 0.03% 160
2021
Q2
$7.92M Sell
48,100
-23,400
-33% -$3.87M 0.03% 162
2021
Q1
$11.8M Buy
+71,500
New +$11.6M 0.05% 91
2020
Q4
Sell
-6,300
Closed -$938K 730
2020
Q3
$938K Buy
6,300
+1,600
+34% +$237K 0.01% 450
2020
Q2
$661K Buy
+4,700
New +$685K 0.01% 423
2020
Q1
Sell
-31,900
Closed -$4.65M 272
2019
Q4
$4.65M Sell
31,900
-32,300
-50% -$4.38M 0.04% 293
2019
Q3
$8.31M Buy
+64,200
New +$8.46M 0.11% 146
2019
Q2
Sell
-37,600
Closed -$5.26M 839
2019
Q1
$5.26M Buy
+37,600
New +$5.04M 0.05% 296

Other funds holding JNJ

HBK Investments's JNJ Position: Q3 2023 in Review

HBK Investments sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 8,455 shares — an estimated $1.4M sold.

HBK Investments first reported a position in JNJ in Q3 2013 and held it in 22 quarters. The position peaked at $60.2M in Q1 2017. 3,679 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • HBK Investments reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 8,455 Johnson & Johnson shares in Q3 2023, an estimated $1.4M.
  • HBK Investments first reported a position in Johnson & Johnson in Q3 2013 and held it in 22 quarters.
  • HBK Investments's Johnson & Johnson position peaked at $60.2M in Q1 2017.
  • 3,679 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.